Z-2073-2016 Class II Terminated

Recalled by Pentax Medical Company — Montvale, NJ

FDA device recall Z-2073-2016 was initiated by Pentax Medical Company on April 6, 2016 and is designated Class II. Reason for recall: Pentax has become aware that operational/cleaning accessories and therapeutic devices (e.g., clips, stents, balloons, etc.) can become lodged in an endoscope's instrument channel. The recall status is terminated (terminated December 21, 2017). Affected quantity: 206 units.

Recall Details

Product Type
Devices
Report Date
July 6, 2016
Initiation Date
April 6, 2016
Termination Date
December 21, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
206 units

Product Description

Laryngo Stroboscope Product Usage Intended to provide optical visualization of, therapeutic access to, the Upper Airway and Vocal Folds. This anatomy includes, but is not restricted to, the organs, tissues and subsystems: Larynx, Pharynx and Vocal Cords. The instrument is introduced via the mouth or the nose, as decided by the physician, when indications consistent with the need for procedure are observed in adult and pediatric patient populations.

Reason for Recall

Pentax has become aware that operational/cleaning accessories and therapeutic devices (e.g., clips, stents, balloons, etc.) can become lodged in an endoscope's instrument channel.

Distribution Pattern

Worldwide Distribution - US (Nation Wide) including Puerto Rico and Internationally to Denmark, Guam

Code Information

Model #VNL-1570STK